Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cardiovascular Revascularization Medicine is Scopus-indexed (Q2, CiteScore 4), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 1553-8389Verify ISSN ↗1878-0938Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$3,490 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 155 / 409 | 62nd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2005–present, best quartile Q2, CiteScore 4.
Cardiovascular Revascularization Medicine is Q2 in Cardiology and Cardiovascular Medicine (rank 155 of 409), by CiteScore 2025.
Cardiovascular Revascularization Medicine is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4, which places it in quartile Q2 at the 62nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.679, quartile Q2, with an H-index of 50.
The publisher lists an article processing charge of about US$3,490 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cardiovascular Revascularization Medicine is published by Elsevier Inc. Its print ISSN is 1553-8389 and its online ISSN is 1878-0938.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Cardiovascular Revascularization Medicine has an h-index of 57 and a 2-year mean of 1.36 citations per paper (OpenAlex). Its Scopus CiteScore is 4, quartile Q2. On 2-year citations it ranks #189 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Cardiovascular Revascularization Medicine published 272 papers in 2025; its busiest recent year was 2022 with 574. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2026), authors are most often from United States (45.1%), Italy (4.4%) and Japan (4.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.